• Health & Medicine

First ‘targeted’ bowel cancer treatment combo approved for NHS use in England 

The first chemotherapy-free drug combination for people with a rare type of bowel cancer has been approved for NHS use in England.   The first chemotherapy-free drug combination for people with a rare type of bowel cancer has been approved for NHS use in England.  

20 November 2020

• Health & Medicine

Chemotherapy free treatment for leukaemia given the green light for NHS in England

A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England. A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England.

13 November 2020

• Health & Medicine

Four new cancer drugs approved on NHS in Scotland

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers. The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

13 November 2020

• Charity News

Charity CEOs warn of irreparable damage to UK research

A crisis in charity research funding caused by the COVID-19 pandemic threatens to delay the pace of life saving discoveries. A crisis in charity research funding caused by the COVID-19 pandemic threatens to delay the pace of life saving discoveries.

13 November 2020

• Health & Medicine
• Policy & Insight

Learning the lessons of COVID-19: Protecting cancer services and research through the pandemic

We're calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve. We're calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve.

9 November 2020

• Health & Medicine

Immunotherapy drug approved for head and neck cancer

Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.    Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.   

26 October 2020

• Science & Technology

UK could lose up to £7.8 billion of medical research funding because of COVID-19 pandemic 

New figures suggest that the UK could lose up to £7.8 billion of investment in life-saving research by 2027 because of the COVID-19 pandemic. New figures suggest that the UK could lose up to £7.8 billion of investment in life-saving research by 2027 because of the COVID-19 pandemic.

23 October 2020

• Policy & Insight

The UK Government’s spending review: Time to invest in the future of cancer care

This autumn the chancellor Rishi Sunak will set out the Government’s spending priorities. Here's why it's time to invest in cancer services and research. This autumn the chancellor Rishi Sunak will set out the Government’s spending priorities. Here's why it's time to invest in cancer services and research.

20 October 2020

• Policy & Insight

Dear Prime Minister: "Please don't delay action again, we're counting on you"

Campaigner Patrick McGuire writes to Boris Johnson about honouring his manifesto commitments in the upcoming Comprehensive Spending Review. Campaigner Patrick McGuire writes to Boris Johnson about honouring his manifesto commitments in the upcoming Comprehensive Spending Review.

16 October 2020

• Policy & Insight

NHS staff shortages: What’s needed to build a sustainable cancer workforce?

We’ve estimated it will cost HEE between £142 million and £260 million more than it already invests to grow the key cancer professions by 45%. We’ve estimated it will cost HEE between £142 million and £260 million more than it already invests to grow the key cancer professions by 45%.

12 October 2020

• Health & Medicine

UK health inequalities: 20,000 more cancer cases a year in the most deprived areas

New figures released today reveal that there are around 20,000 extra cancer cases each year in more deprived areas of the UK. New figures released today reveal that there are around 20,000 extra cancer cases each year in more deprived areas of the UK.

30 September 2020

• Policy & Insight

Opinion: 'Let’s not be short-sighted – the UK’s medical research charities need urgent support'

Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding. Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding.

24 September 2020